HES5 is a basic helix-loop-helix (bHLH) transcription factor that functions as a transcriptional repressor and serves as a key effector of the Notch signaling pathway. In the nervous system, HES5 plays critical roles in neural stem cell maintenance, neurogenesis, gliogenesis, and synaptic plasticity. The gene is highly expressed during embryonic brain development and in adult neurogenic niches, where it maintains the balance between neural progenitor proliferation and neuronal differentiation. Dysregulation of HES5 has been implicated in Alzheimer's disease, brain malformation syndromes, and various neurodevelopmental disorders.
HES5 is a basic helix-loop-helix (bHLH) transcription factor that functions as a transcriptional repressor and serves as a key effector of the Notch signaling pathway. In the nervous system, HES5 plays critical roles in neural stem cell maintenance, neurogenesis, gliogenesis, and synaptic plasticity. The gene is highly expressed during embryonic brain development and in adult neurogenic niches, where it maintains the balance between neural progenitor proliferation and neuronal differentiation. Dysregulation of HES5 has been implicated in Alzheimer's disease, brain malformation syndromes, and various neurodevelopmental disorders.
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Hairy and Enhancer of Split 5</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>HES5</td></tr>
<tr><td><strong>Full Name</strong></td><td>Hairy and Enhancer of Split 5</td></tr>
<tr><td><strong>Chromosome</strong></td><td>1p36.32</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[474085](https://www.ncbi.nlm.nih.gov/gene/474085)</td></tr>
<tr><td><strong>OMIM</strong></td><td>604527</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000197921</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q5JT76](https://www.uniprot.org/uniprot/Q5JT76)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Brain Development Disorders, Autism Spectrum Disorder</td></tr>
<tr><td><strong>Protein Family</strong></td><td>HES family (bHLH transcription factor)</td></tr>
</table>
</div>
HES5 is a member of the HES (Hairy and Enhancer of Split) family of transcriptional repressors, which are essential downstream effectors of Notch signaling. The Notch-HES pathway is a fundamental signaling cascade that controls cell fate decisions throughout development and in adult tissues. In the nervous system, this pathway determines whether neural stem cells maintain their proliferative state, differentiate into neurons, or become glial cells.
The HES family proteins are characterized by a basic helix-loop-helix (bHLH) DNA-binding domain, an Orange domain for protein-protein interactions, and a C-terminal proline or serine-rich transcriptional repression domain. HES5 binds to the canonical E-box sequence "CACGTG" (N-box) and recruits corepressor complexes, including TLE/Groucho proteins, to suppress transcription of target genes.
During development, HES5 is expressed in the ventricular and subventricular zones, where neural stem cells reside. Its expression maintains progenitors in an undifferentiated state by repressing proneural genes such as ASCL1 (MASH1) and NEUROD1. Transient downregulation of HES5 is required for neurons to exit the progenitor state and begin differentiation.
HES5 is a 199-amino acid protein with modular domain structure:
| Domain | Location | Function |
|--------|----------|----------|
| bHLH domain | aa 20-80 | DNA binding, dimerization |
| Orange domain | aa 85-120 | Protein-protein interactions |
| Repressor domain | aa 140-199 | Transcriptional repression |
The basic region of the bHLH domain mediates sequence-specific DNA binding to N-box sequences (CANNTG). The HLH region forms homodimers or heterodimers with other bHLH proteins. The Orange domain allows dimerization with other HES proteins, modulating their activity. The C-terminal domain interacts with corepressor proteins including TLE/Groucho.
HES5 represses transcription through multiple mechanisms:
HES5 demonstrates dynamic expression:
| Brain Region | Developmental Stage | Expression Level |
|--------------|---------------------|-------------------|
| Ventricular zone | Embryonic | High |
| Subventricular zone | Embryonic/Adult | High |
| Dentate gyrus | Adult | High (neurogenic niche) |
| Cortex | Embryonic | High |
| Cortex | Adult | Low/absent |
| Hippocampus | Adult | Low |
In the adult brain, HES5 is restricted to:
HES5 maintains neural progenitor cells in an undifferentiated state:
The HES5-expressing radial glia-like cells in the SVZ and SGZ are the primary neural stem cells in the adult brain. These cells divide asymmetrically to self-renew and produce transit-amplifying cells that generate neurons and glia.
Transient downregulation of HES5 is required for neuronal differentiation:
This sequence ensures that neural stem cells produce neurons in a controlled, sequential manner during development and in adult neurogenic niches.
HES5 also promotes astrogliogenesis:
In mature neurons, HES5 regulates:
| Interactor | Interaction Type | Functional Significance |
|------------|-----------------|------------------------|
| NOTCH1 | Direct regulation | Upstream activator |
| NOTCH2 | Direct regulation | Upstream activator |
| RBPJ | Co-factor | DNA-binding complex |
| MAML | Co-activator | Notch target |
The canonical Notch pathway activates HES5 transcription through RBPJ binding sites in the HES5 promoter. Notch intracellular domain (NICD) translocates to the nucleus and associates with RBPJ to activate transcription.
| Interactor | Interaction Type | Functional Significance |
|------------|-----------------|------------------------|
| ASCL1 | Repression | Proneural activator |
| NEUROD1 | Repression | Neuronal differentiation |
| TLE/Groucho | Interaction | Corepressor recruitment |
HES5 directly represses proneural bHLH transcription factors, creating a negative feedback loop that modulates the Notch-proneural balance.
HES5 dysregulation is implicated in AD pathogenesis:
The relationship between HES5 and AD involves multiple mechanisms:
| Mechanism | Effect | Reference |
|-----------|--------|----------|
| Reduced neurogenesis | Decreased neuronal replacement | [3] |
| Notch dysregulation | Altered cell fate | [1] |
| Synaptic impairment | Memory deficits | [3] |
| Astrocyte reactivity | Neuroinflammation | [2] |
HES5 variants and expression changes are associated with:
Reports link HES5 to ASD:
| Approach | Target | Stage | Indication |
|----------|--------|-------|------------|
| Notch inhibitors | γ-secretase | Research | AD |
| HES5 agonists | HES5 expression | Research | Neurogenesis |
| bHLH modulators | Proneural genes | Research | Differentiation |
HES5 is a critical bHLH transcriptional repressor that serves as a key effector of Notch signaling in the nervous system. Through its repression of proneural genes, HES5 maintains neural stem cells in an undifferentiated state, controls the timing of neuronal differentiation, and promotes astrocyte fate decisions. Dysregulation of HES5 contributes to Alzheimer's disease, brain development disorders, and neurodevelopmental conditions. Understanding the Notch-HES5 axis provides insights into neural stem cell biology and potential therapeutic approaches for neurodegenerative diseases.
The following diagram shows the key molecular relationships involving HES5 Gene discovered through SciDEX knowledge graph analysis: